HLS THERAPEUTICS INC.HLS THERAPEUTICS INC.HLS THERAPEUTICS INC.

HLS THERAPEUTICS INC.

No trades
See on Supercharts
Market capitalization
‪102.40 M‬EUR
−0.78EUR
‪−25.40 M‬EUR
‪58.19 M‬EUR
‪30.76 M‬
Beta (1Y)
0.08

About HLS THERAPEUTICS INC.

CEO
Craig Millian
Headquarters
Etobicoke
Employees (FY)
91
Founded
2014
ISIN
CA40390B1094
FIGI
BBG00Y79GTD3
HLS Therapeutics, Inc.e ngages in commercializing pharmaceutical products. It specializes in central nervous system and cardiovascular markets. The company was founded by Gregory Gubitz and Gilbert Godin on June 5, 2014 and is headquartered in Etobicoke, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange HLS THERAPEUTICS INC. stocks are traded under the ticker 74D.
HLS THERAPEUTICS INC. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for HLS THERAPEUTICS INC. has a max estimate of 7.30 EUR and a min estimate of 2.88 EUR.
74D earnings for the last quarter are −0.20 EUR whereas the estimation was −0.10 EUR which accounts for −96.74% surprise. Estimated earnings for the next quarter are −0.09 EUR. See more details about HLS THERAPEUTICS INC. earnings.
HLS THERAPEUTICS INC. revenue for the last quarter amounts to ‪15.17 M‬ EUR despite the estimated figure of ‪15.55 M‬ EUR. In the next quarter revenue is expected to reach ‪14.50 M‬ EUR.
Yes, you can track HLS THERAPEUTICS INC. financials in yearly and quarterly reports right on TradingView.
74D net income for the last quarter is ‪−5.03 M‬ EUR, while the quarter before that showed ‪−6.45 M‬ EUR of net income which accounts for 21.98% change. Track more HLS THERAPEUTICS INC. financial stats to get the full picture.
Yes, 74D dividends are paid quarterly. The last dividend per share was 0.03 EUR. As of today, Dividend Yield (TTM)% is 4.24%. Tracking HLS THERAPEUTICS INC. dividends might help you take more informed decisions.
Like other stocks, 74D shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HLS THERAPEUTICS INC. stock right from TradingView charts — choose your broker and connect to your account.
74D reached its all-time high on Mar 22, 2021 with the price of 14.00 EUR, and its all-time low was 2.16 EUR and was reached on Nov 28, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 91.00 employees. See our rating of the largest employees — is HLS THERAPEUTICS INC. on this list?
We've gathered analysts' opinions on HLS THERAPEUTICS INC. future price: according to them, 74D price has a max estimate of 7.30 EUR and a min estimate of 2.89 EUR. Read a more detailed HLS THERAPEUTICS INC. forecast: see what analysts think of HLS THERAPEUTICS INC. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HLS THERAPEUTICS INC. EBITDA is ‪19.93 M‬ EUR, and current EBITDA margin is 34.23%. See more stats in HLS THERAPEUTICS INC. financial statements.